ReviewFrontiers in immunology2022

Checkpoint inhibitor immune-related adverse events: A focused review on autoantibodies and B cells as biomarkers, advancements and future possibilities.

John Taylor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.